August 8, 2020

The Niche

Knoepfler lab stem cell blog

multiple sclerosis stem cells

4 min read

Multiple sclerosis (MS) can be an extremely debilitating disease that ultimately is fatal in some patients and reduces life expectancy and quality overall substantially. An MS patient named Caroline Wyatt, who works at the BBC, had the courage to open up in full detail on the BBC about having MS, her experience getting an experimental treatment of stem cells in Mexico, and how she is doing now. It’s a powerful new piece that brings home the complexities of having MS and of getting this hopeful, …Read More

2 min read

For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in a locale near me. Tomorrow, July 11, reportedly the Irvine Stem Cell Treatment Center will open a Sacramento, CA branch. The doctor there will apparently be Thomas A. Gionis (picture …Read More

2 min read

This week the big Winnipeg Free Press story on the Regenetek/Doug Broeska alleged stem cell fraud case broke (covered here on this blog). David Audley was quoted in the story as a Regenetek spokesperson so I asked him for further comment and below is what he emailed me for this post. David Audley: “1. GoodPartners is a consultant to Regenetek, not a partner. We were engaged in December to provide a review of their existing protocol in anticipation of a submission of their study …Read More

4 min read

Who is Doug Broeska and what is Regenetek a Canadian stem cell company doing that is drawing attention of authorities? The Winnipeg Free Press is reporting that Regenetek faces serious charges related to for-profit stem cell therapies. (Update: a followup story in the Free Press has been published). A very thorough article in the newspaper by Melissa Martin and Mary Agnes Welch reports that a “researcher” at the company named Doug Broeska (picture above from LinkedIn) who ran a stem cell trial for Multiple Sclerosis …Read More